雙林股份(300100.SZ):正積極佈局電機、減速器、電機控制器三合一的產品,現已完成平台開發,並獲取五菱客户新項目,預計將於2023年9月份量產
格隆匯7月19日丨有投資者向雙林股份(300100.SZ)提問,“公司減速機或者電機等產品是否有運用到智能機器人上?”
雙林股份回覆稱,公司專注於新能源電動汽車電驅動研發、生產和銷售,產品包括驅動電機、電機控制器、一體化電橋、VMS等,產品應用目前暫不涉及機器人產業。公司目前已有電機和減速器二合一電橋產品,同時公司正在積極佈局電機、減速器、電機控制器三合一的產品,現已經完成平台開發,並獲取五菱客户新項目,預計將於2023年9月份量產。更多公司生產經營相關等信息請您關注公司定期報吿和公吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.